Allianz Asset Management’s Adaptive Biotechnologies ADPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $924K | Buy |
79,300
+66,500
| +520% | +$775K | ﹤0.01% | 1271 |
|
|
2025
Q1 | $95.1K | Buy |
12,800
+100
| +0.8% | +$743 | ﹤0.01% | 1695 |
|
|
2024
Q4 | $76.1K | Buy |
+12,700
| New | +$76.1K | ﹤0.01% | 1661 |
|
|
2022
Q2 | – | Sell |
-366,290
| Closed | -$5.08M | – | 1785 |
|
|
2022
Q1 | $5.08M | Sell |
366,290
-35,215
| -9% | -$489K | ﹤0.01% | 1091 |
|
|
2021
Q4 | $11.3M | Sell |
401,505
-46,530
| -10% | -$1.31M | 0.01% | 891 |
|
|
2021
Q3 | $15.2M | Sell |
448,035
-17,694
| -4% | -$601K | 0.01% | 769 |
|
|
2021
Q2 | $19M | Buy |
465,729
+405,482
| +673% | +$16.6M | 0.02% | 642 |
|
|
2021
Q1 | $2.43M | Sell |
60,247
-351,887
| -85% | -$14.2M | ﹤0.01% | 1214 |
|
|
2020
Q4 | $24.4M | Buy |
412,134
+105,569
| +34% | +$6.24M | 0.02% | 540 |
|
|
2020
Q3 | $14.9M | Buy |
306,565
+60,860
| +25% | +$2.96M | 0.02% | 647 |
|
|
2020
Q2 | $11.9M | Buy |
245,705
+224,347
| +1,050% | +$10.9M | 0.01% | 718 |
|
|
2020
Q1 | $593K | Sell |
21,358
-13,039
| -38% | -$362K | ﹤0.01% | 1586 |
|
|
2019
Q4 | $1.03M | Sell |
34,397
-28,174
| -45% | -$843K | ﹤0.01% | 1711 |
|
|
2019
Q3 | $1.93M | Sell |
62,571
-141,234
| -69% | -$4.35M | ﹤0.01% | 1461 |
|
|
2019
Q2 | $9.84M | Buy |
+203,805
| New | +$9.84M | 0.01% | 1012 |
|